Henri Termeer (English Wikipedia)

Henri A. Termeer Genzyme, 1995–1997, Washington, D.C.: Biotechnology Industry Organization, archived from the original on September 25, 2015, retrieved July 8, 2015

biotechhistory.org

Gavin Rynne; Mark Jones, eds. (2013), Conversations with Henri Termeer (PDF), The Life Sciences Foundation Oral History Program, San Francisco, archived from the original (PDF) on July 21, 2015, retrieved July 7, 2015{{citation}}: CS1 maint: location missing publisher (link) Oral history conducted by Ted Everson, Jennifer Dionisio, Pei Koay, and Arnold Thackray, May 23, December 7, 2006, August 2, 2007, December 18, 2008 & September 30, 2011

bioworld.com

Catherine Shaffer (December 6, 2013). "Moderna Makes Entrance with $40M Round for mRNA Work". BioWorld. Retrieved December 11, 2013.

bloomberg.com

Meg Tirrell (February 16, 2011), Genzyme's Termeer May Follow Health Care CEO Path to Private Equity Firms, Bloomberg, retrieved July 17, 2015
Genzyme's Termeer, Biotechnology Pioneer, May Sell, Bloomberg, September 1, 2010, retrieved July 17, 2015
Verastem Inc (VSTM:NASDAQ GM), Bloomberg, August 30, 2023

boston.com

Henri A. Termeer (April 10, 2011), "Going out on top", Boston.com, The Boston Globe, retrieved July 17, 2015 as told to Scott Helman
Erin Ailworth; Robert Weisman (June 17, 2009). "Virus shuts Genzyme plant, holds up drugs for 8,000". The Boston Globe.
Joshua Boger (May 7, 2007), Building on a System of Outreach, Collaboration, The Boston Globe, retrieved July 8, 2015
Kissinger, Gifford, Termeer attend MGH bicentennial, The Boston Globe, September 19, 2011, retrieved July 16, 2015

bostonglobe.com

Marquard, Bryan; Weisman, Robert (May 13, 2017). "Henri A. Termeer, key biotech leader who built Genzyme into an industry giant, dies at 71". The Boston Globe. Archived from the original on May 15, 2017. Retrieved May 13, 2017.
Robert Weisman (July 12, 2015), How Genzyme became a source of biotech executives, The Boston Globe, retrieved July 17, 2015
Robert Weisman (January 20, 2013), Henri Termeer isn't exactly settling into retirement: Not content to rest on his laurels, the former Genzyme chief stays busy as a tireless advocate for the Massachusetts biotech industry, San Francisco: The Boston Globe, retrieved July 8, 2015

bostonmagazine.com

Francis Storrs (March 2006), The 50 Wealthiest Bostonians, Boston Magazine, archived from the original on November 28, 2016, retrieved July 8, 2015

businessweek.com

investing.businessweek.com

Amicus Therapeutics, Inc. Executive Profile^{[dead link‍]}, BusinessWeek. Accessed April 4, 2008.

cvshealth.com

"PharmaCare Included in Genzyme's Thyrogen(R) Distribution Network". CVS Health. April 21, 2005. Retrieved September 24, 2015.

doi.org

Deegan PB, Cox TM (2012). "Imiglucerase in the treatment of Gaucher disease: a history and perspective". Drug Design, Development and Therapy. 6: 81–106. doi:10.2147/DDDT.S14395. PMC 3340106. PMID 22563238.
Weinreb NJ (August 2008). "Imiglucerase and its use for the treatment of Gaucher's disease". Expert Opinion on Pharmacotherapy. 9 (11): 1987–2000. doi:10.1517/14656566.9.11.1987. PMID 18627336. S2CID 72183308.
Starzyk K, Richards S, Yee J, Smith SE, Kingma W (February 2007). "The long-term international safety experience of imiglucerase therapy for Gaucher disease". Molecular Genetics and Metabolism. 90 (2): 157–63. doi:10.1016/j.ymgme.2006.09.003. PMID 17079176.
"Clofarabine", Drugs in R&D, 5 (4): 213–7, 2004, doi:10.2165/00126839-200405040-00005, PMID 15230627, S2CID 261073158
Zangi L, Lui KO, von Gise A, Ma Q, Ebina W, Ptaszek LM, Später D, Xu H, Tabebordbar M, Gorbatov R, Sena B, Nahrendorf M, Briscoe DM, Li RA, Wagers AJ, Rossi DJ, Pu WT, Chien KR (September 8, 2013). "Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction". Nature Biotechnology. 31 (10): 898–907. doi:10.1038/nbt.2682. PMC 4058317. PMID 24013197.

fda.gov

accessdata.fda.gov

FDA > CDRH > CFR Title 21 Database Search

fiercebiotech.com

Ryan McBride (December 13, 2012), "Ex-Genzyme CEO Termeer returns to his roots at biotech Prosensa", Fierce Biotech, retrieved July 8, 2015
"Prosensa – 2012 Fierce 15", Fierce Biotech, September 19, 2012, retrieved July 8, 2015
John Carrol (September 9, 2014), "Termeer-backed ProQR lays out terms for $75M IPO", Fierce Biotech

forbes.com

Forbes (December 2007). "Henri Termeer Profile". Henri Teemer profile. Archived from the original on December 28, 2001. Retrieved July 10, 2008.
"New Enterprise Associates Closes $2.6 Billion In One Of Largest Venture Funds Ever", Forbes, July 25, 2012, retrieved July 8, 2015

globalgenes.org

"Global Genes and R.A.R.E. Project Announce Tribute to Champions of Hope™ Gala to Honor Rare and Genetic Disease Pioneers, Innovators and Advocates", Global Genes, Dana Point, California, June 27, 2012, retrieved July 9, 2015

harvard.edu

cb.hbsp.harvard.edu

"A Father's Love: Novazyme Pharmaceuticals, Inc. ". Harvard.edu, October 2002. Accessed June 14, 2011.

hms.harvard.edu

"Board of Directors", Fellows of Harvard Medical School

hbr.org

Michael E. Porter (December 1998), "Clusters and the New Economics of Competition", Harvard Business Review

huffingtonpost.com

Myers, Jack (February 10, 2009). "TED Conference 2009: Inspiration and an Uplifting Spirit of Hope for Future Generations". The Huffington Post. Retrieved June 17, 2010.

ibtimes.com

Portero, Ashley. "30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010". International Business Times. Archived from the original on January 7, 2012. Retrieved December 26, 2011.

iht.com

"Genzyme Claims Victory in Prolonged Bid for Bioenvision". International Herald Tribune (France). Associated Press. October 22, 2007. Retrieved November 10, 2007.

liftstream.com

"Prosensa & GSK pool resources to drive Drisapersen in Duchenne". February 26, 2013.

massgeneral.org

"Treatment Programs", Massachusetts General Hospital
Termeer Center Opening Reception, October 2, 2012, retrieved July 9, 2015Talks by MGH President Dr. Peter Slavin, Mass General Cancer Center Director Dr. Daniel Haber, Termeer Center Director Dr. Keith Flaherty, patient John Murphy and donor Henri Termeer

modernatx.com

Henri A. Termeer Joins Moderna Therapeutics Board of Directors, Cambridge, Mass., April 30, 2013, archived from the original on July 8, 2015, retrieved July 8, 2015{{citation}}: CS1 maint: location missing publisher (link)

mtexpress.com

Plasse, Sabina Dana (January 22, 2010). "Facebook challenge offers $1 million for research". Idaho Mountain Express. mtexpress.com. Archived from the original on January 28, 2010. Retrieved June 16, 2010.

nd.edu

Crowley, John. "To Save the Children". Notre Dame Lawyer, Spring 2007. Accessed April 4, 2008.

nih.gov

pubmed.ncbi.nlm.nih.gov

Deegan PB, Cox TM (2012). "Imiglucerase in the treatment of Gaucher disease: a history and perspective". Drug Design, Development and Therapy. 6: 81–106. doi:10.2147/DDDT.S14395. PMC 3340106. PMID 22563238.
Weinreb NJ (August 2008). "Imiglucerase and its use for the treatment of Gaucher's disease". Expert Opinion on Pharmacotherapy. 9 (11): 1987–2000. doi:10.1517/14656566.9.11.1987. PMID 18627336. S2CID 72183308.
Starzyk K, Richards S, Yee J, Smith SE, Kingma W (February 2007). "The long-term international safety experience of imiglucerase therapy for Gaucher disease". Molecular Genetics and Metabolism. 90 (2): 157–63. doi:10.1016/j.ymgme.2006.09.003. PMID 17079176.
"Clofarabine", Drugs in R&D, 5 (4): 213–7, 2004, doi:10.2165/00126839-200405040-00005, PMID 15230627, S2CID 261073158
Zangi L, Lui KO, von Gise A, Ma Q, Ebina W, Ptaszek LM, Später D, Xu H, Tabebordbar M, Gorbatov R, Sena B, Nahrendorf M, Briscoe DM, Li RA, Wagers AJ, Rossi DJ, Pu WT, Chien KR (September 8, 2013). "Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction". Nature Biotechnology. 31 (10): 898–907. doi:10.1038/nbt.2682. PMC 4058317. PMID 24013197.

ncbi.nlm.nih.gov

Deegan PB, Cox TM (2012). "Imiglucerase in the treatment of Gaucher disease: a history and perspective". Drug Design, Development and Therapy. 6: 81–106. doi:10.2147/DDDT.S14395. PMC 3340106. PMID 22563238.
Zangi L, Lui KO, von Gise A, Ma Q, Ebina W, Ptaszek LM, Später D, Xu H, Tabebordbar M, Gorbatov R, Sena B, Nahrendorf M, Briscoe DM, Li RA, Wagers AJ, Rossi DJ, Pu WT, Chien KR (September 8, 2013). "Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction". Nature Biotechnology. 31 (10): 898–907. doi:10.1038/nbt.2682. PMC 4058317. PMID 24013197.

opensecrets.org

Client Profile: Summary, OpenSecrets, 2008

orpha.net

"Imiglucerase on Orpha.net: The portal for rare diseases and orphan drugs".

parentprojectmd.org

"The top 50 thought-leaders in orphan drugs and rare disease" (PDF), World Orphan Drug Congress USA, 2013, retrieved July 20, 2015

partners.org

"Board of Directors", Partners HealthCare System, archived from the original on July 12, 2015, retrieved September 24, 2015

sciencehistory.org

"Biotechnology Heritage Award". Science History Institute. May 31, 2016. Retrieved March 22, 2018.

semanticscholar.org

api.semanticscholar.org

Weinreb NJ (August 2008). "Imiglucerase and its use for the treatment of Gaucher's disease". Expert Opinion on Pharmacotherapy. 9 (11): 1987–2000. doi:10.1517/14656566.9.11.1987. PMID 18627336. S2CID 72183308.
"Clofarabine", Drugs in R&D, 5 (4): 213–7, 2004, doi:10.2165/00126839-200405040-00005, PMID 15230627, S2CID 261073158

terrapinn.com

Terrapinn Holdings Ltd (2015). Mr Henri Termeer: Chief Executive Officer, Former Genzyme. Orphan Drug Congress. Retrieved September 27, 2015.

trentonian.com

Edelstein, Jeff. "Look Who's Talking: John Crowley, dad, entrepreneur, and subject of the upcoming film Extraordinary Measures" Archived March 14, 2012, at the Wayback Machine, The Trentonian, January 11, 2010. Accessed February 17, 2011. "Princeton's Crowley family, from left, Megan, Aileen, John, Patrick, and John Jr. John Crowley, a Princeton Township resident, is the father of two children with Pompe disease."

verastem.com

"Board of Directors", Verastem, 2015, retrieved July 9, 2015
"About", Verastem

web.archive.org

Gavin Rynne; Mark Jones, eds. (2013), Conversations with Henri Termeer (PDF), The Life Sciences Foundation Oral History Program, San Francisco, archived from the original (PDF) on July 21, 2015, retrieved July 7, 2015{{citation}}: CS1 maint: location missing publisher (link) Oral history conducted by Ted Everson, Jennifer Dionisio, Pei Koay, and Arnold Thackray, May 23, December 7, 2006, August 2, 2007, December 18, 2008 & September 30, 2011
"Board of Directors", Partners HealthCare System, archived from the original on July 12, 2015, retrieved September 24, 2015
Marquard, Bryan; Weisman, Robert (May 13, 2017). "Henri A. Termeer, key biotech leader who built Genzyme into an industry giant, dies at 71". The Boston Globe. Archived from the original on May 15, 2017. Retrieved May 13, 2017.
Portero, Ashley. "30 Major U.S. Corporations Paid More to Lobby Congress Than Income Taxes, 2008–2010". International Business Times. Archived from the original on January 7, 2012. Retrieved December 26, 2011.
World Health Organization. Regulatory Matters WHO Drug Information 5:3 1991. p 123
Edelstein, Jeff. "Look Who's Talking: John Crowley, dad, entrepreneur, and subject of the upcoming film Extraordinary Measures" Archived March 14, 2012, at the Wayback Machine, The Trentonian, January 11, 2010. Accessed February 17, 2011. "Princeton's Crowley family, from left, Megan, Aileen, John, Patrick, and John Jr. John Crowley, a Princeton Township resident, is the father of two children with Pompe disease."
Forbes (December 2007). "Henri Termeer Profile". Henri Teemer profile. Archived from the original on December 28, 2001. Retrieved July 10, 2008.
Francis Storrs (March 2006), The 50 Wealthiest Bostonians, Boston Magazine, archived from the original on November 28, 2016, retrieved July 8, 2015
Henri A. Termeer Genzyme, 1995–1997, Washington, D.C.: Biotechnology Industry Organization, archived from the original on September 25, 2015, retrieved July 8, 2015
Plasse, Sabina Dana (January 22, 2010). "Facebook challenge offers $1 million for research". Idaho Mountain Express. mtexpress.com. Archived from the original on January 28, 2010. Retrieved June 16, 2010.
Henri A. Termeer Joins Moderna Therapeutics Board of Directors, Cambridge, Mass., April 30, 2013, archived from the original on July 8, 2015, retrieved July 8, 2015{{citation}}: CS1 maint: location missing publisher (link)

wsj.com

Geeta Anand (November 2005), "Why Genzyme Can Charge So Much for Cerezyme", The Wall Street Journal, retrieved July 9, 2015

blogs.wsj.com

James A. White (April 8, 2010), "Ex-Wyeth CEO Bob Essner Moves to Private Equity's Carlyle Group", The Wall Street Journal, retrieved July 17, 2015

xconomy.com

Luke Timmerman (May 13, 2013), "Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)", Xconomy, retrieved July 9, 2015

youtube.com

"John Crowley On The Today Show 2001". Youtube.com, September 2001. Accessed June 16, 2008.

zmags.com

viewer.zmags.com

"Journey of the Heart". PharmaVoice.com, January 2009. Accessed April 8, 2009.